Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term glucocorticoid treatment in patients with polymyalgia rheumatica: can we just move a step forward? Comments on "Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis".

× No keyword cloud information.

6 in total

Review 1. Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease.

Authors: M Cutolo; R H Straub
Journal: Clin Exp Rheumatol Date: 2000 Nov-Dec Impact factor: 4.473

2. C-reactive protein concentrations as predictors of glucocorticoid-free remission in patients with polymyalgia rheumatica.

Authors: Ciro Manzo
Journal: Int J Rheum Dis Date: 2021-01-10 Impact factor: 2.454

3. Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients.

Authors: G Myklebust; J T Gran
Journal: Scand J Rheumatol Date: 2001 Impact factor: 3.641

Review 4. Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis.

Authors: Alberto Floris; Matteo Piga; Elisabetta Chessa; Mattia Congia; Gian Luca Erre; Maria Maddalena Angioni; Alessandro Mathieu; Alberto Cauli
Journal: Clin Rheumatol Date: 2021-08-20 Impact factor: 3.650

5. The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity.

Authors: Marco A Cimmino; Massimiliano Parodi; Carlomaurizio Montecucco; Roberto Caporali
Journal: BMC Musculoskelet Disord Date: 2011-05-14 Impact factor: 2.362

6. Polymyalgia rheumatica patients with and without elevated baseline acute phase reactants: distinct subgroups of polymyalgia rheumatica?

Authors: Diane E Marsman; Nathan den Broeder; Nadine Boers; Frank H J van den Hoogen; Alfons A den Broeder; Aatke van der Maas
Journal: Clin Exp Rheumatol Date: 2020-04-03 Impact factor: 4.862

6 in total

1 in total

1. The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios.

Authors: Ciro Manzo; Elvis Hysa; Alberto Castagna; Marco Isetta
Journal: J Pers Med Date: 2022-02-22

1 in total